GraniteShares 2x Long DELL Daily ETF (NASDAQ: DLLL)

Latest news for GraniteShares 2x Long DELL Daily ETF (NASDAQ:DLLL)

GraniteShares 2x Long DELL Daily ETF

GraniteShares 2x Long META Daily ETF (FBL)

New ETFs

ETFs

DELL

DLLL

INTC

INTW

QCML

QCOM

TSYY


GraniteShares has launched 3 leveraged single-stock ETFs for Dell, Intel, and Qualcomm. These funds aim to amplify exposure to these tech stocks and are the first of their kind.

New Leveraged ETFs Let Traders Bet Big On Dell, Intel, Qualcomm

WIIM

Bausch Health shares are trading higher after the company reported better-than-expected Q4 sales.

WeRide shares are trading lower on possible profit-taking after gaining last week when Nvidia disclosed a 1.74 million share stake in a 13F filing.

Like clockwork, Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) posted strong earnings results, delivering fourth-quarter adjusted earnings per share of 66 cents on top of revenue of $180.55 billion. Both figures beat their respective analyst consensus targets of 64 cents and $180.01 billion. Unfortunately, the one avenue that disappointed Wall Street was the <a href="https://www.benzinga.com/news/earnings/25/02/43846469/walmart-q4-earnings-shine-but-soft-fy26-outlook-disappoints-street">forward guidance</a>, sending the stock tumbling down.
To be sure, <a href="https://www.benzinga.com/quote/WMT/earnings">earnings misses themselves are rare</a>. Going back to May 2020, Walmart has only failed to meet analysts' estimates twice. In terms of revenue, the big-box retailer has a perfect record during the aforementioned period. However, concerns over the stock — particularly due to macroeconomic or geopolitical events — are nothing new. This framework may offer hope amid the current downbeat news.
Isolated to just the fourth-quarter results, the storyline appears quite optimistic. For example, Walmart's gross margin rate was up 53 basis points, thanks in large part to its core domestic business. Operating income increased by 8.3% to about $600 billion. Further, same-store sales for Walmart U.S. climbed by 4.6%, excluding fuel.
However, management disclosed that first-quarter adjusted EPS may only land between 57 cents and 58 cents, noticeably below the estimate of 64 cents. For fiscal year 2026, adjusted EPS may range between $2.50 to $2.60, below analysts' consensus view of $2.76. Naturally, <a href="https://www.benzinga.com/markets/equities/25/02/43811296/walmart-set-for-record-sales-amid-tariff-concerns-one-of-the-better-positioned-retailers-to-mitigate-or-manage-through-tariffs-says-analyst">new tariffs</a> introduced by President Donald Trump on goods produced in China, India, Mexico and Canada weighed heavily on investors.
Nevertheless, it's important to remember that in May 2019, Walmart warned that prices would <a href="https://www.reuters.com/article/business/walmart-says-higher-china-tariffs-will-increase-prices-for-us-shoppers-idUSKCN1SM18X/">rise</a> due to the trade war at the time with China. Such disclosures ultimately didn't hurt the stock. That may have been for the reasons UBS analyst Michael Lasser is providing now for why the retailer could be resilient: "price leadership, buying power, and global sourcing capabilities."
<h2 class="wp-block-heading">Historical Price Trends Suggest Volatility In Walmart Stock As A Discount</h2>
Perhaps the sweetest irony amid the red ink is that Walmart — the leader of the everyday low-pricing business model — is now offering a discount on its own equity. Typically, volatility represents a warning sign. However, for a relevant behemoth like Walmart, the downside has consistently shown itself to be a discounted opportunity.
Primarily, long-side speculators largely benefit from the upward bias of Walmart stock. Using data since January 2019, a purely stochastic or temporal view of Walmart reveals that a position entered at the beginning of the week has about a 55.2% chance of rising by the end of it. Over the next four weeks, the long odds actually rise to over 62%.
However, something interesting happens when Walmart stock encounters unusual volatility. For the current week, the security is on pace to lose more than 6%. Whenever Walmart incurs a one-week loss between 5% and 10%, the subsequent week sees long odds pop to nearly 67%. This stat stays consistent for the next four weeks, resulting in a median return (assuming the positive scenario) of 2.89%.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20140807/WMT-stock-probability-gambit-1024x576.jpg" alt="" class="wp-image-791673" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20140807/WMT-stock-probability-gambit-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20140807/WMT-stock-probability-gambit-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20140807/WMT-stock-probability-gambit-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20140807/WMT-stock-probability-gambit.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
To be fair, such big losses in Walmart stock are rare: it's only happened six times since January 2019 so the dataset is extremely small. However, if Walmart manages to mitigate the weekly red ink to below 5%, the odds would still favor the long-side speculator. Over the next four weeks following modest volatility, the long odds are still around 62%.
While historical trends aren't guaranteed to repeat, the optimistic view — despite tariff fears — makes sense. Walmart doesn't just exercise scale and pricing power, which are enormous advantages to begin with. For years, it has also <a href="https://www.retaildive.com/news/walmart-reportedly-pushing-for-higher-margin-goods-to-boost-online-profits/516646/">diversified</a> into higher-margin goods, which was reflected in the fourth-quarter report.
<h2 class="wp-block-heading">A Bold Options Strategy to Consider</h2>
Given the bounce-back tendencies of Walmart&#8217;s stock, buy-and-hold investors may consider the present dip as a possible entry point. For aggressive traders, the red ink is arguably more compelling. With so much fear baked into the forward guidance and the impact of tariffs, Walmart call options appear relatively underpriced.
The most daring traders may consider a multi-leg options strategy called the <a href="https://www.benzinga.com/money/bull-spread">bull call spread</a> for the options chain expiring March 21; specifically, the 97.50/100 bull spread. This transaction calls for buying the $97.50 call and simultaneously selling the $100 call. By taking the proceeds from the short call, the trader partially offsets the debit paid for the long call.
At time of writing, the net debit required for this trade is $109, which is also the most that can be lost. On the other end, the maximum reward possible is $141 or a payout of over 129%. Share prices will need to rise by over 2.8% at expiration to hit the $100 short-strike target, thus triggering the payout.
To note, bull call spreads are capped-risk, capped-reward transactions. The lower-priced long call meets the potential obligation implied by the higher-priced short call. However, many traders are willing to engage such transactions because it allows them to potentially profit handsomely from relatively small moves in the underlying equity.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/25/02/43862827/this-palantir-technologies-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday">This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday</a></li>
</ul>
Image: Shutterstock

Earnings

Earnings Beats

Long Ideas

Options

Movers

Options Corner: Walmart's Best Rollback Could Be For Its Own Shares

Trading in Analog Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) is flat Thursday. This follows yesterday&#8217;s gain of over 21% which was driven by an <a href="https://www.benzinga.com/news/earnings/earnings-beats/25/02/43855595/analog-devices-posts-q4-beat-industry-shows-early-signs-cyclical-recovery-analysts">earnings release</a>.
It isn't a surprise the rally stalled out where it did. Stocks frequently hit resistance at price levels that had been resistance before. That's the case with Analog and the $242 level.
Good traders can recognize which price levels are important in markets. They know that when a stock reaches one of these levels, the tendency is for them to either reverse, break out, or break down. These are called support and resistance levels.
Back in May when ADI reached $242, the sellers came out of the woodwork. They overpowered the buyers and pushed the price lower.
When this happened, many of the traders and investors who bought shares around $242 came to believe their decision to buy was a mistake. Some of them decided to sell their shares, but they didn't want to lose money.
As a result, they made the decision to hold onto their shares and eventually sell if they can get out at breakeven. So, when the stock returned to $242.00 in July they placed sell orders. This large concentration of these orders created resistance at the same price that had been resistance before.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20150030/120-1024x547.png" alt="" class="wp-image-791787" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20150030/120-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20150030/120-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20150030/120-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20150030/120.png 1518w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/25/02/43858501/whats-moving-markets-thursday">Palantir Rally Loses Steam, Walmart Outlook Disappoints: What&#8217;s Driving Markets Thursday?</a>
Now that the price has returned to this level, a similar dynamic is occurring. People who bought shares around $242 in July are placing sell orders so they can finally exit the position at breakeven. Buyer remorse has once again caused resistance to form at a price that had previously been resistance.
When stocks reach important resistance levels, they tend not to stay at them for an extended period of time. They tend to either reverse and sell off, or break out and move higher.
This is why Analog is on the radar screen of many traders as a possible idea.
If the resistance breaks and the shares move higher, this will mean that the sellers have left the market. They have finished or canceled.&nbsp; This could be a setup for another bullish move.
If buyers enter the market, they may have a tough time finding someone to buy shares from. They may need to push the price higher to draw sellers back into the market. This could force an uptrend to form.
If the resistance doesn't break, sellers may fear missing out and reduce the prices they are willing to sell for. If they start to undercut each other this could force a downtrend to form.
Important price levels are like a fork in the road. When stocks reach them, they tend to go one way or another. Some savvy traders are waiting to see which way Analog Devices will trend before they take positions.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43861405/dave-portnoy-calls-for-a-crypto-cleanup-but-heres-what-could-make-that-tricky">Dave Portnoy Calls For A &#8216;Crypto Cleanup,&#8217; But Here&#8217;s What Could Make That Tricky</a></li>
</ul>
Image: Shutterstock

Technicals

Trading Ideas

Stock Of The Day: Is Analog Devices Due For Breakout Or Breakdown?

Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $295.13, a high estimate of $350.00, and a low estimate of $245.00. This upward trend is apparent, with the current average reflecting a 7.06% increase from the previous average price target of $275.67.
<img src="https://www.benzinga.com/files/images/story/2025/1740081694_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The perception of Carvana by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Baker</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$260.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$320.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Colin Sebastian</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$250.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$340.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$250.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Jeff Lick</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$350.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Ronald Josey</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$277.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$280.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$330.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>David Lantz</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$275.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Jeff Lick</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Nicholas Jones</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$320.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$330.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$245.00</td>
<td>$240.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Carvana. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Carvana compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Carvana's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Carvana's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CVNA/analyst-ratings?utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Carvana analyst ratings.</a>
<h2>Delving into Carvana's Background</h2>
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
<h3>Carvana: A Financial Overview</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Carvana's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 31.81%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Carvana's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.33% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 14.95%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.17%, the company showcases effective utilization of assets.
Debt Management: Carvana's debt-to-equity ratio is notably higher than the industry average. With a ratio of 10.06, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

CVNA

What 15 Analyst Ratings Have To Say About Carvana

In the preceding three months, 9 analysts have released ratings for Clean Harbors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLH#NYSE">CLH</a>), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $270.33, a high estimate of $290.00, and a low estimate of $254.00. Highlighting a 0.94% decrease, the current average has fallen from the previous average price target of $272.89. 
<img src="https://www.benzinga.com/files/images/story/2025/1740081683_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Clean Harbors. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Hoffman</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$285.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Noah Kaye</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$254.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$270.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Devin Dodge</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$270.00</td>
<td>$284.00</td>
</tr>
<tr>
<td>David Manthey</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$272.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$268.00</td>
<td>$268.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$268.00</td>
<td>$268.00</td>
</tr>
<tr>
<td>Noah Kaye</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$256.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Michael Hoffman</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$290.00</td>
<td>$270.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Clean Harbors. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Clean Harbors compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Clean Harbors's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Clean Harbors's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CLH/analyst-ratings?utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Clean Harbors analyst ratings.</a>
<h2>Delving into Clean Harbors's Background</h2>
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
<h3>Unraveling the Financial Story of Clean Harbors</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining Clean Harbors's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 11.99% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Clean Harbors's net margin excels beyond industry benchmarks, reaching 7.53%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Clean Harbors's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.64%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.6%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.2.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Clean Harbors's Future

OneSpaWorld shares are trading lower after the company on Wednesday reported a Q4 adjusted EPS miss and issued Q1 revenue guidance below estimates.

During the last three months, 7 analysts shared their evaluations of Exact Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $71.14, a high estimate of $86.00, and a low estimate of $65.00. This current average represents a 0.5% decrease from the previous average price target of $71.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1740081673_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Exact Sciences among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$65.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Bruce Jackson</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$65.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$72.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$86.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Mark Massaro</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$75.00</td>
<td>$65.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Exact Sciences. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Exact Sciences compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Exact Sciences's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Exact Sciences's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EXAS/analyst-ratings?utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Exact Sciences analyst ratings.</a>
<h2>All You Need to Know About Exact Sciences</h2>
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
<h3>Exact Sciences's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Exact Sciences displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 12.78%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Exact Sciences's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -5.4%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Exact Sciences's ROE stands out, surpassing industry averages. With an impressive ROE of -1.19%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Exact Sciences's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.57%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Exact Sciences's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.86.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EXAS

Expert Outlook: Exact Sciences Through The Eyes Of 7 Analysts

Ratings for Krystal Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRYS#NASDAQ">KRYS</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $217.33, a high estimate of $221.00, and a low estimate of $212.00. Surpassing the previous average price target of $215.75, the current average has increased by 0.73%.
<img src="https://www.benzinga.com/files/images/story/2025/1740081666_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of Krystal Biotech by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Yigal Nochomovitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$215.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Josh Schimmer</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Overweight</td>
<td>$215.00</td>
<td>-</td>
</tr>
<tr>
<td>Geulah Livshits</td>
<td>Chardan Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$218.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$221.00</td>
<td>$221.00</td>
</tr>
<tr>
<td>Geulah Livshits</td>
<td>Chardan Capital</td>
<td>Maintains</td>
<td>Buy</td>
<td>$212.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$221.00</td>
<td>$221.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$221.00</td>
<td>$221.00</td>
</tr>
<tr>
<td>Geulah Livshits</td>
<td>Chardan Capital</td>
<td>Maintains</td>
<td>Buy</td>
<td>$212.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$221.00</td>
<td>$221.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Krystal Biotech. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Krystal Biotech compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Krystal Biotech's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Krystal Biotech's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KRYS/analyst-ratings?utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Krystal Biotech analyst ratings.</a>
<h2>About Krystal Biotech</h2>
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
<h3>Financial Milestones: Krystal Biotech's Journey</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Krystal Biotech's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 879.91%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Krystal Biotech's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 32.42% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Krystal Biotech's ROE stands out, surpassing industry averages. With an impressive ROE of 3.15%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Krystal Biotech's ROA stands out, surpassing industry averages. With an impressive ROA of 2.86%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KRYS

A Glimpse Into The Expert Outlook On Krystal Biotech Through 9 Analysts

Microvast Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NYSE">MVST</a>) short percent of float has fallen 3.68% since its last report. The company recently reported that it has 16.38 million shares sold short, which is 15.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.81 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Microvast Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740081663_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Microvast Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Microvast Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Microvast Holdings's peer group average for short interest as a percentage of float is 5.04%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

MVST

How Is The Market Feeling About Microvast Holdings?

Credo Technology Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NYSE">CRDO</a>) short percent of float has fallen 10.51% since its last report. The company recently reported that it has 6.96 million shares sold short, which is 4.94% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.01 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Credo Technology Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740081657_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Credo Technology Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Credo Technology Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Credo Technology Group's peer group average for short interest as a percentage of float is 5.11%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CRDO

Is the Market Bullish or Bearish on Credo Technology Group?

During the last three months, 16 analysts shared their evaluations of Toast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>), revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">8</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Toast, revealing an average target of $43.5, a high estimate of $50.00, and a low estimate of $30.00. This current average reflects an increase of 9.32% from the previous average price target of $39.79. 
<img src="https://www.benzinga.com/files/images/story/2025/1740081656_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Toast. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Perlin</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>David Hynes</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$48.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Tien-Tsin Huang</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Timothy Chiodo</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$47.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Rufus Hone</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$48.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>David Koning</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Josh Baer</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$50.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$42.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Rayna Kumar</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$46.00</td>
<td>-</td>
</tr>
<tr>
<td>Jeff Cantwell</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$30.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Rufus Hone</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$45.00</td>
<td>-</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$40.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Peter Heckmann</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$45.00</td>
<td>$34.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Toast. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Toast compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Toast's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Toast's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TOST/analyst-ratings?utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Toast analyst ratings.</a>
<h2>Get to Know Toast Better</h2>
Toast is a us-based restaurant technology company that provides point-of-sale, payment processing, and various software services to 127,000 restaurant locations across the United States as of September 2024. The firm generates sales from software subscription fees, as a percentage take rate from each financial transaction it processes, from loan origination and servicing fees from its Toast Capital arm, and from hardware installation and professional services. Unlike competitors, Toast intermediates every payment transaction on its platform, processing some $126 billion in gross platform volume in 2023. The firm's product offerings span point-of-sale systems, inventory and payroll management, delivery integration, e-commerce ordering, reservation management, and loyalty programs.
<h3>Toast's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Toast displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 26.45%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Toast's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 4.29%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Toast's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 4.14%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Toast's ROA excels beyond industry benchmarks, reaching 2.56%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.03.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TOST

A Glimpse Into The Expert Outlook On Toast Through 16 Analysts

TeraWulf's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NYSE">WULF</a>) short percent of float has risen 7.52% since its last report. The company recently reported that it has 71.77 million shares sold short, which is 23.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.23 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>TeraWulf Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740081652_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for TeraWulf has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing TeraWulf's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, TeraWulf's peer group average for short interest as a percentage of float is 9.37%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

WULF

What Does the Market Think About TeraWulf?

Louisiana-Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPX#NYSE">LPX</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $122.75, with a high estimate of $135.00 and a low estimate of $108.00. Marking an increase of 4.03%, the current average surpasses the previous average price target of $118.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1740081649_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive Louisiana-Pacific is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Chercover</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$123.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Matthew McKellar</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Ketan Mamtora</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$108.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Michael Roxland</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$135.00</td>
<td>$117.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Louisiana-Pacific. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Louisiana-Pacific compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Louisiana-Pacific's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Louisiana-Pacific's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/LPX/analyst-ratings?utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Louisiana-Pacific analyst ratings.</a>
<h2>Discovering Louisiana-Pacific: A Closer Look</h2>
Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.
<h3>Louisiana-Pacific: Financial Performance Dissected</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Louisiana-Pacific's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -0.82%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 12.47%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Louisiana-Pacific's ROE stands out, surpassing industry averages. With an impressive ROE of 5.41%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Louisiana-Pacific's ROA stands out, surpassing industry averages. With an impressive ROA of 3.53%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Louisiana-Pacific's debt-to-equity ratio is below the industry average. With a ratio of 0.22, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Louisiana-Pacific: 4 Analysts Share Their Views

HealthEquity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) has outperformed the market over the past 10 years by 7.61% on an annualized basis producing an average annual return of 18.76%. Currently, HealthEquity has a market capitalization of $9.80 billion. 
Buying $100 In HQY: If an investor had bought $100 of HQY stock 10 years ago, it would be worth $572.84 today based on a price of $113.12 for HQY at the time of writing.
<h3>HealthEquity's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740081609_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Here's How Much You Would Have Made Owning HealthEquity Stock In The Last 10 Years

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>BMO Capital analyst Ameet Thakkar downgraded SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) from Market Perform to Underperform and raised the price target from $13 to $15. SolarEdge shares closed at $19.63 on Wednesday. <a href="https://www.benzinga.com/quote/SEDG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Craig-Hallum analyst Jeremy Hamblin downgraded the rating for Axon Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) from Buy to Hold and announced a $625 price target. Axon Enterprise shares closed at $593.42 on Wednesday. <a href="https://www.benzinga.com/quote/AXON/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital analyst Arun Viswanathan downgraded Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Outperform to Sector Perform and lowered the price target from $84 to $56. Celanese shares closed at $54.91 on Wednesday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Roth MKM analyst Chip Moore downgraded Eos Energy Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) from Buy to Neutral and raised the price target from $4 to $5. Eos Energy Enterprises shares closed at $4.82 on Wednesday. <a href="https://www.benzinga.com/quote/EOSE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Nicholas Campanella downgraded the rating for DTE Energy Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTE#NYSE">DTE</a>) from Overweight to Equal-Weight and lowered the price target from $137 to $135. DTE Energy shares closed at $130.38 on Wednesday. <a href="https://www.benzinga.com/quote/DTE/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="574" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20145520/image-173-1024x574.png" alt="" class="wp-image-791778" style="width:506px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20145520/image-173-1024x574.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20145520/image-173-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20145520/image-173-768x431.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20145520/image-173.png 1127w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43844722/walmart-dropbox-and-3-stocks-to-watch-heading-into-thursday">Walmart, Dropbox And 3 Stocks To Watch Heading Into Thursday</a></li>
</ul>

Downgrades

Markets

AXON

EOSE

SEDG

This Celanese Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

JPMorgan analysts shared their take on Devon Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) and Occidental Petroleum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) following their latest earnings reports, highlighting key financial moves and production outlooks. Here&#8217;s <a href="https://www.benzinga.com/25/02/43828144/devon-energy-shines-as-analysts-praise-efficiency-capex-cuts">what you know</a>.
JPMorgan on DVN: For Devon Energy, analysts noted that the company delivered one of the strongest earnings prints of the season, with a 3% oil production beat leading to a 6% increase in cash flow. The company's 2025 guidance was better than expected, with a more capital-efficient plan that increases oil output while cutting spending by 5%. According to the analysts, strong performances in the Eagle Ford and Rockies assets, along with the successful integration of the Grayson Mill acquisition, contributed to the earnings beat. Devon also raised its fixed dividend by 9% and repurchased $301 million in stock during the quarter, with plans to return up to 70% of its free cash flow to investors in 2025.
JPMorgan on OXY: Occidental Petroleum's stock surged 4.4% post-earnings despite a weaker-than-expected first-quarter 2025 outlook and $1.1 billion in special charges, including impairments and environmental reserves. JPMorgan analysts suggested the stock's strength was driven by a sizable fourth-quarter beat, accelerated debt reduction, and a 9% dividend increase. Occidental generated $1.35 billion in free cash flow in the quarter, using $500 million to reduce debt and achieving its $4.5 billion deleveraging target seven months ahead of schedule. The company also announced $1.2 billion in non-core asset sales, with plans to use the proceeds for 2025 debt maturities.
Price Action: Shares of Devon Energy were up 2.24% at $38.41, while Occidental Petroleum gained 2.34% to trade at $52.18 as of Tuesday afternoon.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43856737/applovin-stock-tumbles-as-short-seller-takes-a-closer-look-at-whats-driving-enormous-gains">AppLovin Stock Tumbles As Short Seller Takes Closer Look At What&#8217;s Driving Enormous Gains</a></li>
</ul>
Image Via Shutterstock.

JPMorgan Weighs In On Devon Energy And Occidental Petroleum After Earnings

After a giant run to the north,defence contractor and AI stock Palantir (PLTR) finally began retracing into support levels earlier this week, before its next run to the upside.
Though the chart is quite bullish, the new political administration announced defense budget cuts that traders assumed would affect the stock. Traders are both shorting the stock and are positioned to take profits into support near $100 and below.&nbsp;
That&#8217;s the perfect setup for a long put butterfly trade on PLTR.
PLTR&#8217;s relative resistance zone sits right around $125 as I&#8217;m writing this. The relative support is near $65.&nbsp;
Given that, the way to structure the long put butterfly for further downside is this:
<ul>
<li>Buy to open 1 PLTR 21 Mar 100 puts </li>
<li>Sell to open 2 PLTR 21 Mar 80 puts </li>
<li>Buy to open 1 PLTR 21 Mar 60 puts </li>
</ul>
This long put butterfly holds a current debit of $2.10. The total risk is the debit you paid &#8211; $210.00.
The total potential profit is $2,000 (the distance between strikes times 100) and the cost of the debit ($2,000 &#8211; $210= $1,790).&nbsp;
It is extremely rare to collect all this premium. Instead, I like to consider 200%-350% profit of the investment&nbsp;
The strategy result provides only two choices to exit the trade:
<ul>
<li>To sell the butterfly that is performing at your target parameters – particularly once the middle strike is tested </li>
<li>To sell the butterfly right if the chart does nothing, or once your threshold for loss is hit. Mine is typically 65-70% with these positions.  </li>
</ul>
Consider exiting the trade with 10 days or more into expiration as the closer the options get to expiration, the more volatile the options become.
<a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0220&amp;utm_campaign=wallstreetadvantage">5 Breakout Stocks. Every Friday. Before the Crowd Knows.</a>
The Whisper Index uncovers stocks on the verge of major moves—before the mainstream catches on. It's how we spotted Insmed, Sprouts, and Uber before their 20%+ gains. This week's new picks drop Friday—will you see them first or hear about them later? <a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0220&amp;utm_campaign=wallstreetadvantage">Get My Edge</a>
Image via Shutterstock

Opinion

Cash In on Palantir's Fall From Grace

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Jefferies analyst James Heaney upgraded the rating for Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) from Underperform to Hold and raised the price target from $55 to $100. Roku shares closed at $92.41 on Wednesday. <a href="https://www.benzinga.com/quote/ROKU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Matthew Lofting upgraded the rating for BP p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) from Underweight to Neutral. BP shares closed at $34.54 on Wednesday. <a href="https://www.benzinga.com/quote/BP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Christopher Danely upgraded NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) from Neutral to Buy and raised the price target from $210 to $290. NXP Semiconductors shares closed at $245.58 on Wednesday. <a href="https://www.benzinga.com/quote/NXPI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Graham Doyle upgraded Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) from Neutral to Buy. Philips shares closed at $25.05 on Wednesday. <a href="https://www.benzinga.com/quote/PHG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Susquehanna analyst Mehdi Hosseini upgraded Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) from Neutral to Positive and raised the price target from $75 to $125. Lam Research shares closed at $87.66 on Wednesday. <a href="https://www.benzinga.com/quote/LRCX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying BP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="524" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172-1024x524.png" alt="" class="wp-image-791761" style="width:587px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172-1024x524.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172-768x393.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20144731/image-172.png 1285w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>

Upgrades

Price Target

LRCX

NXPI

ROKU

This BP Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Thursday

Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares are trading volatile Wednesday, after experiencing momentum last week as investors anticipate an update on the company's<a href="https://www.benzinga.com/trading-ideas/movers/25/02/43812953/super-micro-computer-stock-continues-to-climb-whats-going-on"> delayed financial filings</a>.
What To Know: Super Micro has been under scrutiny since its independent auditor, Ernst &amp; Young, resigned last October over governance and transparency concerns, leading to the delay in quarterly and full-year filings. However, an independent Special Committee found no evidence of fraud or misconduct by management or the board. The company has until Feb. 25 to submit its reports to the U.S. Securities and Exchange Commission.
Last week, Super Micro reported preliminary first-quarter results and reaffirmed its commitment to filing the delayed reports before the deadline. Shares initially dipped after the announcement but rebounded after CEO Charles Liang expressed confidence that the filings would be completed on time. The company also set a revenue target of $40 billion for 2026, according to CNBC.
Analysts have reacted to the developments with price target adjustments. JPMorgan's Samik Chatterjee raised the target from $23 to $35 while maintaining an Underweight rating. Wedbush analyst Matt Bryson maintained a Neutral stance and raised the target from $24 to $40. Loop Capital's Ananda Baruah maintained a Buy rating and increased the target from $40 to $50. Loop Capital has been optimistic about Super Micro, expecting benefits from improved internal controls, while Wedbush remains cautious, citing unresolved uncertainties.
Super Micro shares closed Tuesday up 16.5% and continued to rise Wednesday morning, gaining 5.95% to trade at $103.90, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro. </a>
SMCI Price Action: Super Micro Computer shares were down 0.95% at $59.65 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="513" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20134854/Screenshot-2025-02-20-at-13.48.31-1024x513.png" alt="" class="wp-image-791630" style="width:565px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20134854/Screenshot-2025-02-20-at-13.48.31-1024x513.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20134854/Screenshot-2025-02-20-at-13.48.31-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20134854/Screenshot-2025-02-20-at-13.48.31-768x385.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/20134854/Screenshot-2025-02-20-at-13.48.31.png 1529w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43858501/whats-moving-markets-thursday">Palantir Rally Loses Steam, Walmart Outlook Disappoints: What&#8217;s Driving Markets Thursday?</a></li>
</ul>
Image via Shutterstock.

SMCI

Super Micro Computer Shares Are Volatile Today: What's Going On?

GraniteShares has launched three new <a href="https://www.benzinga.com/etfs">leveraged single-stock ETFs</a> that provide amplified exposure to Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>), Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), and Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>). The latest additions, revealed on Feb. 13, further expand the firm's rapidly growing suite of leveraged and short ETFs, bringing its total offerings to 23.



The newly launched leveraged single-stock ETFs include GraniteShares 2x Long QCOM Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCML#NASDAQ">QCML</a>), GraniteShares 2x Long DELL Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLLL#NASDAQ">DLLL</a>), GraniteShares 2x Long INTC Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTW#NASDAQ">INTW</a>).



Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/02/43694659/elm-wealth-debuts-etf-with-362-million-in-assets-75-devoted-to-global-equities">Elm Wealth Debuts ETF With $362 Million In Assets, 75% Devoted To Global Equities</a>



These are the first leveraged single-stock ETFs for Dell, Intel, and Qualcomm. These funds provide investors with a more accessible way to trade these tech names without the need for margin accounts or concerns over margin calls. Additionally, the developing options market around these ETFs presents traders with further strategic possibilities.



These funds are designed for traders who are bullish on the AI revolution and looking to amplify their exposure to these key technology stocks. By leveraging performance at a two-times multiplier, investors stand to magnify both potential gains and losses based on daily price movements.



Beyond its leveraged products, GraniteShares recently made a bold entry into the options income space with its innovative YieldBoost strategy. The first fund in this lineup, GraniteShares YieldBoost TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSYY#NASDAQ">TSYY</a>), was launched in December last year. It is structured to generate income by selling put options.



Read Next: 



<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/02/43663523/new-treasury-etfs-target-liquidity-as-vanguard-expands-fixed-income-lineup">New Treasury ETFs Target Liquidity As Vanguard Expands Fixed-Income Lineup</a></li>
</ul>



Photo: Shutterstock

Comments

GraniteShares 2x Long DELL Daily ETF

News

Latest news for GraniteShares 2x Long DELL Daily ETF (NASDAQ:DLLL)

Thursday, February 13, 2025

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga